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Abstract
Introduction: Reversible myocardial depression occurs early in severe sepsis and septic shock. The question of
whether or not early ventricular depression or dilatation is associated with lower mortality in these patients
remains controversial. Most studies on this topic were small in size and hence lacked statistical power to answer
the question. This meta-analysis attempted to answer the question by increasing the sample size via pooling
relevant studies together.
Methods: PubMed, Embase (and Medline) databases and conference abstracts were searched to July 2012 for
primary studies using well-defined criteria. Two authors independently screened and selected studies. Eligible
studies were appraised using defined criteria. Additional information was sought the corresponding authors if
necessary. Study results were pooled using random effects models. Standardized mean differences (SMD) between
survivor and non-survivor groups were used as the main effect measures.
Results: A total of 62 citations were found. Fourteen studies were included in the analysis. The most apparent
differences between the studies were sample sizes and exclusion criteria. All studies, except four pre-1992 studies,
adopted the Consensus definition of sepsis. Altogether, there were >700 patients available for analysis of the left
ventricle and >400 for the right ventricle. There were no significant differences in left ventricular ejection fractions,
right ventricular ejection fractions, and right ventricular dimensions between the survivor and non-survivor groups.
When indexed against body surface area or body height, the survivors and non-survivors had similar left ventricular
dimensions. However, the survivors had larger non-indexed left ventricular dimensions.
Conclusion: This meta-analysis failed to find any evidence to support the view that the survivors from severe
sepsis or septic shock had lower ejection fractions. However, non-indexed left ventricular dimensions were mildly
increased in the survivor group but the indexed dimensions were similar between the groups. Both survivors and
non-survivors had similar right ventricular dimensions.
Introduction
The phenomenon of sepsis related myocardial dysfunc-
tion has been recognized for over three decades [1].
One of the earliest studies by Weisel et al. in 1977,
using pulmonary artery catheter thermodilution method
measured left ventricular stroke work index, observed
that not only was left ventricular depression common in
patients with sepsis, but was also potentially reversible
[2]. They also found that the left ventricular systolic
function was reduced in non-survivor. Six years later,
Hoffman et al., using gated cardiac scintigraphy, docu-
mented that right ventricular ejection fraction (RVEF)
was depressed in patients with septic shock compared
to normal [3]. It was unclear from this study whether
the survivors exhibited a better baseline right ventricular
function. The most quoted study on this subject is
Parker and co-authors’ 1984 landmark paper which
reported approximately half of the 20 patients with sep-
tic shock in the study had severely reduced baseline left
ventricular ejection fraction (LVEF), and that the mean
LVEF was paradoxically lower in survivors [4]. Using
radionuclide cineagiography, they also showed that
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survivors had dilated left ventricles (LV). In a subse-
quent study, Parker et al. further found that survivors of
septic shock also had depressed initial RVEF, a finding
that was not shared by Vincent et al., who noted that
survivors from septic shock had markedly higher initial
RVEF in two studies [5,6].
While many physicians believe poor LVEF have better
outcome in patients with sepsis, some conflicting data
have started to emerge in recent years. For example,
Vieillard-Baron et al., by examining the hemodynamic
parameters in septic shock patients, found that the
initial LVEF were similar in survivors and non-survivors
[7]. Pulido et al. also failed to find any association
between 30- or 100-day mortality with initial ventricular
dysfunction [8]. Some studies also casted doubts about
the earlier claims that survivors from severe sepsis or
septic shock have larger ventricular size [7,9].
Despite all these studies, the debates of whether or not
ventricular dysfunction or dilatation (increased ventricu-
lar cavity size) is associated with lower mortality in severe
sepsis or septic shock continue. One of the main reasons
is the small sample size in majority of these studies
lacked the statistical power to detect genuine differences
in effect sizes. In light of this continuing uncertainty, we
conducted this meta-analysis to assist in clarifying the
situation. The goals of this meta-analysis are: (1) to criti-
cally appraise the best available observational studies that
correlated venticular function and/or dimension with
mortality in adult patients with severe sepsis or septic
shock; (2) to synthesize the relevant data and determine
if ventricular dysfunction or dilatation is associated with
lower mortality rate; and (3) to list the main difficulties
encountered in past studies and to propose some sugges-
tions for future studies on this subject.
Methods
Study identification
Our search strategy began by breaking the research ques-
tion down to: (1) patient type (study population); (2) indi-
cator or indices; and (3) outcomes. For patient type, we
included only severe sepsis or septic shock; for indicator,
we used myocardial depression and any synonyms; for
outcomes, we looked for mortality and any synonyms.
Primary studies dated July 2012 and earlier were searched
using PubMed and Embase (including Medline). The fol-
lowing terms (some with truncation) were searched as
key and text words: ‘Sepsis OR septic shock [title]’ AND
‘((Ventricular OR cardiac OR myocardial) AND (failure
OR depression OR dysfunction OR function OR impair-
ment OR dimension OR dilat*)) OR (ejection fraction)
[title]’ AND ‘(death OR mortality OR surviv* OR out-
come OR predict* OR prognos*)’. We limited the search
to human studies, English language, clinical study,
outcome study, clinical trials, article, article in press,
conference abstract, or conference paper. The reference
lists of all eligible studies were examined to search for
other relevant studies.
Study eligibility
Two investigators (SJH and MN) independently reviewed
the titles and abstracts of all relevant studies; all potential
relevant studies were retrieved. When disagreement
occurred, the reviewers resolved the discrepancies by
consensus. Selection criteria used to identify studies
were: prospective or retrospective observational studies;
adult patients with either severe sepsis or septic shock;
the initial measurements must be obtained objectively
and as early as practicable; and used mortality as one of
the outcome. The 1992 Consensus definitions of sepsis
and organ failure was applied in all studies except for
those published before 1992 [10]. For these pre-1992 stu-
dies, all of which recruited septic shock patients, we
adopted the definitions of septic shock as specified by the
primary authors and the minimum criteria had to be: (1)
positive blood culture or documented source of infection;
(2) hypotension; and (3) clinical evidence of tissue hypo-
perfusion (such as lactic acidosis, oliguria, or decreased
mental state). Studies were excluded if they: included
minors (aged <18 years), were unclear about the methods
of recruitment, duplicated studies, or contained insuffi-
cient information to extract the data.
Appraisal of study quality
Most of the studies were descriptive in nature and were
not designed as true prognosis studies. We therefore
modified an appraisal checklist for prognosis study
developed by the Centre for Evidence Based Medicine,
Oxford, to assess the quality of the studies [11]. Details
of the appraisal items are shown in Table 1. Studies that
received more than one ‘No’ or ‘Unclear’ to the ques-
tions were excluded.
Data abstraction
Data abstraction was conducted by two investigators in
each study to obtain information on year of publication,
country, patients’ demographics, sample size, ventricular
function and dimension data, mortality, and other clinical
data. Any disagreements were resolved by consensus. We
contacted the primary investigators to provide further
information when data were missing or unclear. The stu-
dies were excluded if the authors did not respond.
The following data were abstracted: for LV systolic
function, LVEF and LV fractional area contraction; for
LV dimension, LV end-diastolic diameter (LVEDD) or
volume (LVEDV); for RV systolic function, RVEF and
RV stroke volume change; and for RV dimension, RV
end-diastolic diameter (RVEDD), volume (RVEDV), or
area (RVEDA).
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Data analysis
The meta-analysis was performed using STATA with
mais package. Patients were divided into two groups:
survivors and non-survivors from severe sepsis or septic
shock. Data from different studies were combined to
obtain a pooled outcome effect measure and unless spe-
cified otherwise, all data were expressed as standardized
mean difference (SMD) (95% confidence interval (CI)),
SMD, which is the weighted mean difference (survivors
minus non-survivors) of the outcome measure (for
example, LVEF). An overall SMD of zero represents no
difference between the survivors and non-survivors. A
negative value indicates survivors had smaller value, and
a positive value indicates survivors had larger value.
Since outcome data were presented in form of continu-
ous data, and different studies might use different vari-
able outcomes (for example, LVEDD or LVEDV for
ventricular size) or different methods (for example,
radionuclide vs. echocardiography) to obtain the same
variable outcome, the SMD was calculated as described
by DerSimonian and Laird’s random effects model [12].
Heterogeneity was tested using Cochran’s Q test. A
P value of < 0.05 was considered as indication of signifi-
cant heterogeneity. I2 statistics were computed from
Cochran’s Q test as described by Higgins et al. [13]. I2 is
the percentage variation in SMD attributable to hetero-
geneity, and values between 25% and 50% indicate low
heterogeneity, whereas between 50% and 75% and >75%
indicate moderate and high heterogeneity, respectively.
Before the analysis, we formed a prior hypothesis that if
heterogeneity existed in the LV function studies, the
source could be due to: (1) the difference in the defini-
tions of sepsis (that is, pre-1992 vs. post-1992 consensus
definition); (2) mortality (for example, in-hospital,
30-day vs. 90-day mortality); (3) whether or not the
study included patients with severe sepsis; and (4)
whether or not patients with history of cardiac disease
were excluded. To explore this, we decided that a meta-
regression analysis containing the above four covariates
should be carried out if the heterogeneity existed [14].
Random permutation test for significance was used to
adjust for multiple testings [14].
Small-study effects (also known as ‘publication bias’)
were examined by funnel plots. To avoid subjectivity in
the interpretation of funnel plots, we tested for plot
symmetry by Egger’s regression test [15]. Further assess-
ment of the publication bias was tested using the Duval
and Tweedie non-parametric ‘trim and fill’ method. This
method estimates the number and outcomes of missing
studies, and adjusts the meta-analysis to incorporate the
imputed missing data [16]. Due to the small number of
studies, trim and fill analysis was not performed for RV
function and dimension analysis.
Results
Study identification and selection
The literature search yielded 62 citations: 38 from
PubMed and 24 from Embase. Eighteen of these were
duplicates that appeared in both databases. A total of 44
abstracts were screened. Twenty-seven were excluded
mainly due to lack of survival and/or cardiac function
data (18 citations) (Figure 1). Seventeen citations were
retrieved for appraisal, and a further 10 were excluded
due to inclusion of non-adults or non-septic patients in
the population or due to insufficient data. Examination
of the reference lists of the retrieved studies identified
seven relevant citations. Finally, a total of 14 primary
studies were included in this systematic review (Table 2)
[6-9,17-26].
Qualitative summary
Characteristics of the included studies
The characteristics of the included studies are summarized
in Table 2. All studies were published between 1984 and
July 2012, and included septic shock patients. Four studies
also included patients with severe sepsis [8,9,24,25]. Four
studies published prior to 1993 defined septic shock based
on clinical diagnosis and included all of the following
three criteria: (1) evidence of infection (either sources
identified or positive cultures); (2) hypotension; and
Table 1 Appraisal checklist for study quality.
Recruitment
Was the study cohort representative of adult population with severe sepsis or septic shock? (Yes/No/Unclear)
Were the patients recruited at an early point in the course of sepsis? (Yes/No/Unclear)
Were eligible patients recruited consecutively? Were all eligible patients within the study period recruited? (Yes/No/Unclear)
Outcome and follow-up
Was ‘mortality’ clearly defined? (Yes/No/Unclear)
Was patient follow-up sufficiently long and complete given the type of mortality defined? (Yes/No/Unclear)
Measurement
Were all measurements obtained objectively using an established method? (Yes/No/Unclear)
Were the initial measurements made sufficient early in the course of sepsis? (i.e. within 24 hours of diagnosis or onset of symptoms)
(Yes/No/Unclear)
Did the patients receive the same number of measurements using the same method at the same stage? (Yes/No/Unclear)
Were the assessors blinded from the measurements or outcome? (Yes/No/Unclear)
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(3) oliguria [6,17-19]. However, only one of the four stu-
dies also included two of the systemic inflammatory
response syndrome (SIRS) criteria [19]. Post-1993 studies
used the ACCP/SCCM Consensus Conference definition
of severe sepsis or septic shock in their recruitment. All
eligible patients were recruited in all studies. All studies
recruited patients within 24 h of onset of symptoms except
for one, which recruited patients ‘as early as possible after
diagnosis’ [25].
Five studies did not list out the sources of sepsis in
the cohorts [6-8,17,18]. The sources of sepsis found in
the rest of the studies were typical of that normally
found in ICU - pneumonia, urosepsis, bacteremia, and
abdominal sepsis (Table 3). The exclusion criteria, how-
ever, varied greatly among the studies (Table 3). While
some studies had clear exclusion criteria, some were
unclear or not mentioned [6,20,21]. Most studies
excluded patients with cardiac-related disease, three stu-
dies did not [9,17,23], and two were silent in this regard
[6,18]. One study found their cohort was free from
regional wall motion abnormality post recruitment [21].
The types of cardiac-related disease were diverse, but
commonly included heart failure, previous myocardial
infarction, and/or valvular disease. Four studies excluded
patients with suboptimal echo images [9,21,25,26].
The measurements and outcomes are summarized in
Table 4. Outcomes were commonly reported as in-hospital
mortality. Two studies reported 28- or 30-day all-cause
mortality [7,8], and one 90-day all cause mortality [26]. In
four studies, the non-survivors died of refractory shock or
protracted sepsis [6,18,19,24]. LV functions were com-
monly reported as LVEF except for one which used LV
Figure 1 Workflow of studies identification.
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fractional area contraction. One study used RV stroke
volume change as surrogate for RV function whereas the
rest used RVEF. Ventricular end-diastolic diameter, area,
and volume were variably used for indicating the LV or RV
dimension. Some studies indexed the dimension to body
surface area (BSA) or height (for example, LV end-diastolic
volume index and RV end-diastolic diameter index). The
assessment methods used in these studies varied and
reflected the standard of assessments at the time - studies
published before and up to 1992 used pulmonary artery
Table 2 Characteristics of included studies.
Author Year Country Study
population
Definition of sepsis
and septic shocka
Excluded underlying
cardiac-related disease
Mean age
(years)
Sample
size (M/F)
Kimchi et al. 1984 USA Septic shock Author No 65 25 (11/14)
Dhainaut et al. 1988 France Septic shock Author - 47 23 (-/-)
Vincent et al. 1989 Belgium Septic shock Author Yes - 34 (11/23)
Vincent et al. 1992 Belgium Septic shock Author - 59 68 (45/23)
Jardin et al. 1999 France Septic shock Consensus Yes 55 90 (52/38)
McLean et al. 2007 Australia Severe sepsis,
septic shock
Consensus No 63 40 (23/17)
Cariou et al. 2008 France Septic shock Consensus Yes 59 10 (7/3)
Etchecopar-Chevreuil et al. 2008 France Septic shock Consensus Yes 56 35 (19/16)
Vieillard-Baron et al. 2008 France Septic shock Consensus Yes 65 67 (50/17)
Sturgess et al. 2010 Australia Septic shock Consensus No 65 21 (13/8)
Furian et al. 2012 Brasil Severe sepsis,
septic shock
Consensus Yes 51 45 (16/29)
Landesberg et al. 2012 Israel Severe sepsis,
septic shock
Consensus Yes 61 262 (159/
103)
Pulido et al. 2012 USA Severe sepsis,
septic shock
Consensus Yes 65 106 (53/53)
Weng et al. 2012 China Septic shock Consensus Yes 66 61 (33/28)
aAuthor: Definition of sepsis and septic shock was defined by author but included at least positive culture or documented sources of infection, hypotension, and
oligouria. Consensus: The ACCP/SCCM consensus conference definition was used.
Table 3 Summary of types of sepsis and exclusion criteria.
Author Year Types of sepsis Exclusion criteria
Kimchi et al. 1984 Not clear, but included ARDS Aged <18 or >85 years; pregnancy
Dhainaut et al. 1988 - ARDS
Vincent et al. 1989 Pulmonary and pleura; gastrointestinal; other HF; MI; recent CPR or cardiac surgery
Vincent et al. 1992 - -
Jardin et al. 1999 - Cardiopulmonary disease
McLean et al. 2007 Pulmonary; abdominal; urosepsis; bacteremia; skeletal;
skin
Aged <18 years; pregnancy
Cariou et al. 2008 Pneumonia; urosepsis; bacteremia; peritoneal Suboptimal echo images; none has regional wall
motion abnormality
Etchecopar-Chevreuil et al. 2008 Pneumonia; abdominal; urosepsis; skin; other Other cause of shock; cardiac disease; arrhythmia;
moribund status or withhold treatment; leukopenia
Vieillard-Baron et al. 2008 Not clear, but patients had either acute lung injury or
ARDS
HF; moribund; did not survive for >48 h
Sturgess et al. 2010 Pulmonary; abdominal; neurologic; fasciitis; catheter-
related; mediastinitis
Aged <18 years; valvular disease
Furian et al. 2012 Pulmonary; abdominal; urosepsis Aged >80 years; HF; liver failure; bone marrow failure;
in immunosuppressed state
Landesberg et al. 2012 Pulmonary; gastrointestinal; wound; vascular surgery or
limb ischemia; genitourinary; orthopedic; skeletal
Valvular disease; MI
Pulido et al. 2012 - Aged <18 years; congenital heart disease; valvular
disease; coronary heart disease; known abnormality in
recent echo
Weng et al. 2012 Pneumonia; bacteremia; peritonitis; other Aged <18 years; valvular disease; post-thoracic
operation; MI; suboptimal echo; moribund
ARDS, acute respiratory distress syndrome; CPR, cardiopulmonary resuscitation; HF, heart failure; MI, myocardial infarction.
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Table 4 Measurements.
Author Year Outcome (mortality) measure Cardiac assessment method LV function
(mean ± SD)
LV dimension
(mean ± SD)
RV function
(mean ± SD)
RV dimension
(mean ± SD)
Kimchi et al. 1984 In-hospital all cause Radionuclide LVEF
(46 ± 16%)
- RVEF
(37 ± 2%)
RVEDVI
(98 ± 10 mL/m2)
Dhainaut et al. 1988 In-hospital refractory shock PAC-TD - - RVEF
(30 ± 12%)
-
Vincent et al. 1989 In-hospital protracted sepsis PAC-TD - - RVEF
(25 ± 8%)
-
Vincent et al. 1992 In-hospital refractory shock PAC-TD - - RVEF
(38 ± 16%)
RVEDVI
(90 ± 31 mL/m2)
Jardin et al. 1999 In hospital all cause TEE LVEF
(49 ± 15%)
LVEDVIa
(69 ± 24 mL/m2)
- -
McLean et al. 2007 In hospital all cause TTE LVEF
(48 ± 15%)
LVEDD
(47 ± 10)
- -
Cariou et al 2008 In hospital all cause TEE LVFAC
(46 ± 19%)
LVEDA
(16 ± 6 cm2)
- -
Etchecopar-Chevreuil et al. 2008 In-hospital all cause TEE LVEF
(47 ± 20%)
LVEDV
(97 ± 25 mL)
- -
Vieillard-Baron et al. 2008 28-day all cause TEE LVEF
(51 ± 17%)
LVEDVIa
(63 ± 23 mL/m2)
- -
Sturgess et al. 2010 In-hospital all cause TTE LVEF
(43 ± 14%)
LVEDVIa
(67 ± 24 mL/m2)
- -
Furian et al. 2012 In-hospital sepsis TTE LVEF
(57 ± 13%)
LVEDD/ht
(28 ± 3 mm/m)
- RVD (TTE)
(24 ± 4 mm)
Landesberg et al. 2012 In-hospital all cause TTE LVEF
(59 ± 11%)
LVEDD
(46 ± 10 mm)
LVEDVIa
(56 ± 18 mL/m2)
RVSV change
(7.5 ± 3.7 mL)
RVEDA
(21 ± 6 cm2)
Pulido et al. 2012 30-day all cause TTE LVEF
(57 ± 15%)
LVEDD
(46 ± 10 mm)
- -
Weng et al. 2012 90-day all cause TTE LVEF
(55 ± 16%)
LVEDV
(72 ± 24 mL)
- -
aI represents index to body surface area.
LVEDA, LV end-diastolic area; LVEDD, LV end-diastolic diameter; LVEDV, LV end-diastolic volume; LVEF, LV ejection fraction; LVFAC, LV fractional area contraction; PAC-TD, Pulmonary artery catheter-thermodilution;
Radionulcide, radionuclide-gated cardiac cineangiography; RVD, RV diameter; RVEDA, RV end-diastolic area; RVEDVI, RV end-diastolic volume index; RVEF, RV ejection fraction; RVSV change, RV stroke volume change;
TEE, transesophageal echocardiography; TTE, transthoracic echocardiography;.
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catheter or radionuclide, and all studies published in 1999
and after utilized echocardiography (either transesophageal
or transthoracic) as the standard methods of assessments.
Quantitative summary
Left ventricle (function and dimension) and mortality
Figure 2 shows the Forest plot of the pooled results of the
weighted difference of the 11 studies. Total sample size
was 762. The pooled SMD was -0.13 (-0.36 to 0.10), indi-
cating there was no significant difference between the sur-
vivor and non-survivors in terms of LV function (P =
0.284). Statistical heterogeneity was mild (I2 = 45.1%; P =
0.052). Meta-regression analysis shows that none of the
covariates proposed in our prior hypothesis contributed to
the heterogeneity observed (P = 0.201) (Table 5). The
symmetry of funnel plot suggested the absence of small
study effects or publication bias (Egger’s test for small-
study effects: P = 0.181) (Figure 3A). Trim and fill analysis
also did not impute any missing studies.
The pooled SMD for LV dimensions indexed to BSA or
body height was 0.16 (-0.25 - 0.57), indicating that there
was no significant difference in LV dimension between
survivors and non-survivors (P = 0.439) (Figure 4).
However, the non-indexed dimensions were mildly
increased in survivors (SMD = 0.22 (0.03 - 0.41); P =
0.023). When pooled together (718 patients), the overall
SMD for LV dimension demonstrated a mild but signifi-
cant increase (SMD = 0.24 (0.04 - 0.44); P = 0.019), indi-
cating survivors had larger LV dimensions. Overall
heterogeneity was mild (I2 = 44.1%, P = 0.065), but mod-
erate heterogeneity was present among those studies uti-
lizing indexed dimension (I2 = 70.4%, P = 0.009).
No small-study effects or publication bias were found
Figure 2 Standardized mean difference (SMD) for LV function in survivor and non-survivors. Forest plot showing the SMDs for different
studies and the overall SMD. Negative or positive SMDs imply smaller or larger LVEF or LVFAC in the survivors. TEE, transesophageal
echocardiography; TTE, transthoracic echocardiography.
Table 5 Meta-regression analysis for potential covariates
contributing to heterogeneity.
Covariates Coefficient 95% CI P
value
Outcome measures
In-hospital vs. 30-day/90-day mortality
-0.19 -0.66 to
0.29
0.372
Patient types
Septic shock vs. severe sepsis and
septic shock
0.42 -0.03 to
0.87
0.062
Definition
Consensus vs. non-consensus
-0.26 -1.62 to
1.10
0.66
Exclusion of existing heart-related
condition
0.027 -0.78 to
0.84
0.94
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(P = 0.613) (Figure 3B). Trim and fill analysis imputed
one ‘missing’ study, but did not alter the overall SMD
(0.21 (0.14 - 0.41)) and heterogeneity (I2 = 45.3%, P =
0.05) significantly.
Right ventricle (function and dimension) and mortality
Only five studies (a total of 412 patients) were included
for RV function analysis. There was no significant differ-
ence in RV function between survivors and non-survivors
Figure 3 Funnel plot for small-study effects. Funnel plot showing possible publication bias due to small-study effects. (A) Funnel plot for LV
function studies. (B) Funnel plot for LV dimension study.
Figure 4 Standardized mean difference (SMD) for LV dimension in survivor and non-survivors. Forest plot showing the SMDs for different
studies and the overall SMD. Studies were divided into two groups: Indexed, where LV dimension were indexed to body surface area or height,
and not indexed. Subtotal SMD for each group are also shown. Negative or positive SMDs imply smaller or larger LV dimension in the survivors.
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(pooled SMD = 0.19 (-0.42 - 0.79); P = 0.545). The het-
erogeneity was high (I2 = 81.9%, P < 0.001) (Figure 5,
upper panel). We noticed that one of the study could be
an outlier (17), however, excluding the study did not
improve the heterogeneity probably due to the small
number of studies (I2 = 77.9%; P = 0.004). There was also
no significant difference in RV dimension between the
survivors and non-survivors (pooled SMD = 0.09 (- 0.37 -
0.54); P = 0.713) (Figure 5, lower panel). Heterogeneity
was also high (I2 = 68.9%, P = 0.022). Test for small-
study effects was not performed due to the small number
of studies.
Discussion
This meta-analysis provides pooled estimates of RV and
LV function and dimension in patients with severe sepsis
and septic shock from 14 individual studies. Using a set
of well-defined inclusion criteria, we found that there
was not enough evidence to support the view that survi-
vors from severe sepsis or septic shock suffered from
Figure 5 Standardized mean difference (SMD) for RV function and dimension in survivor and non-survivors. Forest plot showing the
SMDs for different studies and the overall SMD. Upper panel, Forest plot for RV function; lower panel, Forest plot for RV dimension. Negative or
positive SMDs imply smaller or larger LV dimensions in the survivors.
Huang et al. Critical Care 2013, 17:R96
http://ccforum.com/content/17/3/R96
Page 9 of 13
early LV dysfunction. When indexed to BSA or body
height, the LV dimensions were similar in survivors and
non-survivors. However, un-indexed dimensions and
pooled results suggested that the LV were mildly
enlarged in survivors. There were no statistical significant
differences in RV function or dimensions between survi-
vors and non-survivors.
LV depression is a well-established phenomenon
among patients with severe sepsis or septic shock [27].
Multiple mechanisms are believed to be responsible for
sepsis-induced LV depression, including mitochondrial
dysfunction, oxidative stress, inflammatory actions, and
myocardial injury [28]. Using radionuclide cineangiogra-
phy, Parker and colleagues observed that survivors from
septic shock developed acute LV and RV depression and
dilatation which normalized with recovery, hence the
term ‘reversible myocardial depression’ [4,5]. Similar
findings were made by Jardin [21]. Yet, a number of sub-
sequent studies failed to reproduce Parker’s results. For
example, we analyzed the 1984 study results from Kimchi
et al. and could not find any significant differences in
LVEF or RVEF between survivors and non-survivors
from septic shock (43 ± 13% vs. 51 ± 22% for LVEF (P =
0.232) and 35 ± 2% vs. 39 ± 5% for RVEF (P = 0.439))
[17]. Vincent et al., on the other hand, showed that survi-
vors from septic shock had better right ventricle function
[6,19]. There are several explanations for the discor-
dances reported by these studies, including sample size,
definition of sepsis and septic shock, study population,
types of cardiac investigations, and effects of therapy.
Sample size
Earlier studies usually had smaller sample sizes and sig-
nificant group size imbalance. For example, the original
study by Parker et al. had only 20 patients with seven
non-survivors, Kimchi et al. had 25 with only eight non-
survivors, and Vincent et al. had 34 patients (23 non-
survivors) with septic shock. The main problems arise
from small studies are that they tend to result in impre-
cise estimates and are more likely to find extreme
results. The latter of these can account for inter-study
discordant. To detect a 10% difference in LVEF between
two groups (assuming a SD of 15%), one needs at least
70 patients (35 in each group) to achieve 80% power. A
5% difference will need over 300 patients in total. While
more recent studies tended to be larger in size, few of
them had the necessary sample size to provide a conclu-
sive result.
Definition of severe and time of recruitment
Some primary studies used different definitions of septic
shock for recruiting patients, and those published before
the Consensus definitions defined septic shock differently.
Even with the publication of the Consensus definitions,
the process has not been made easier [10]. For instance,
depending on whether a restricted or a liberal approach is
used, applying the consensus definition resulted in a range
of incidences of severe sepsis (6% to 27%) and septic shock
(4% to 9%) in the same study [29]. This highlighted the
difficulty in recruiting patients in sepsis studies. Not only
could the differences in definitions and recruitment strin-
gency affect the type of patients recruited, but the timing
of recruitment could also contribute. One typical situation
is that not all SIRS criteria are present at start of infection,
which itself is difficult to define [30]. Although some stu-
dies described the times of recruitment and when the first
assessments were done, others were not so explicit prob-
ably due to the difficulty in defining the onset of sepsis,
which might have occurred before admission to ICU.
Arguably, some studies might report the worst values,
while other might have reported the values on Day 1.
Recruiting patients of different types or at different stages
could inevitably affect the composition of study popula-
tion, hence the generalizability.
Study population
To have a homogeneous study population across differ-
ent studies is a challenge in systematic reviews. Hetero-
geneity of study populations can arise from two sources:
(1) inclusion; and (2) exclusion. Although the study
populations in all of the studies were severe sepsis and
septic shock, the sources of sepsis varied. Fortunately,
the sources of sepsis found were comparable in most of
the included studies, and were typical to that found in
general ICU. On the other hand, the exclusion criteria
varied widely among the studies. The most common
exclusion factor was the presence of pre-existing cardiac
conditions. Although it is understandable that excluding
these patients would reduce the risk of type I error
(false-positives) of finding sepsis-induced myocardial
depression, such exclusion could be a curb on giving
the answer if pre-existing cardiac conditions would pre-
dispose patients to sepsis-induced myocardial depression
and/or increase the risk of death. In the original study
by Parker et al., four of the 20 patients had underlying
cardiac conditions (coronary heart disease and cardio-
myopathy), but this did not increased the risk of death
(OR = 0.6; 95% CI = 0.06 to 5.6) [4]. In our previous
study, none of the 12 patients with pre-existing cardiac
conditions developed sepsis-induced myocardial depres-
sion and the presence of cardiac conditions did not
increase the risk of death statistically (OR = 2.4; 95%
CI = 0.5 to 10.7) [9]. Similar findings were found in a
study by ver Elst et al. where previous myocardial infarct
did not increase mortality in septic shock (OR = 2.1;
95% CI = 0.5 to 8.3) [31]. These studies suggested that
pre-existing cardiac conditions neither altered the risk
of sepsis-induced myocardial depression nor increased
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the risk of death in severe sepsis and septic shock. As
the total sample size was still small in these studies,
more research is required in this area.
Assessment methods
In the last three decades, there has been a clear shift in
assessment methods for EFs in these studies - from inva-
sive and to non-invasive. Temporally, radionuclide angio-
graphy was the mainstream in the earliest research,
followed by pulmonary artery catheter thermodilution,
and finally by echocardiography in modern era. Some
doubts existed in relation to the comparability of LVEF
obtained by echocardiography and radionuclide angiogra-
phy. Takenaka et al. found that LVEF measurements by
the two methods could yield different estimates as a result
of the state of the patients such as anxiety [32]. More
recent studies, however, demonstrated that the two meth-
ods have good comparability [33,34]. The comparability of
RVEF by thermodilution and radionuclide however was
not as good [35]. Of note, Vincent et al. found that RVEF
from thermodilution could be underestimated in the pre-
sence of tricuspid regurgitations [36]. The complicated
shape of the right ventricle precludes the use of echocar-
diography to measure RVEF. Due to a lack of strong evi-
dence to support comparability among the three methods,
readers quoting EFs for survivors and non-survivors need
to mention the methods used.
Effects of therapy
Depending on the time of cardiac assessments, fluid resus-
citation had the potential effects of altering the ventricular
dimensions and possibly function. However, most of the
studies were not clear whether fluid had been adminis-
tered before or after measurements. The use of vasopres-
sors and/or inotropes is another factor that could affect
the findings. Vieillard-Baron et al. found that while some
(39%) patients with septic shock exhibited ‘primary’ global
hypokinesia (depressed LV function) at admission, some
(21%) developed ‘secondary’ global hypokinesia 24 to 48 h
after hemodynamic support by norepinephrine [7]. This
‘secondary’ hypokinesia could be partially reversed by
dobutamine. The authors could not rule out a causative
relationship between noradrenaline and hypokinesia, but
pointed out that the hypokinesia could be the direct dele-
terious effects of the associated increase in afterload on a
latent dysfunctioning heart in sepsis. If this is true, then
studies that had their initial assessments done within 24 h
of onset of symptoms could have underestimated the
extent of myocardial depression in their cohorts. This
could have implications in the interpretation of myocardial
depression and mortality.
Mechanical ventilation is another potential confounding
factors that could affect the ventricular function and
dimension in sepsis via heart-lung interactions. The
change in ventilation practice since the ARDSNet study in
2000 [37] is a possible bias or confounders for ventricular
function and dimension. However, the effects of mechani-
cal ventilation, in particular protective ventilation, were
not explored due to a lack of consistent ventilation data.
In this regards, it is noteworthy that most eligible studies
contained a mixed population of sepsis, instead of a pure
population with acute lung injury or acute respiratory dis-
tress syndrome. Hence, the ventilator settings might be
different for different patients.
Effects of indexation on LV dimensions
Our meta-analysis found that when LV dimensions were
indexed against BSA or body height, no differences
between survivors and non-survivors were found in the
pooled results. However, the survivors displayed mildly
dilated LV ventricles when non-indexed dimensions were
used. Of interest, in Landesberg et al.’s study, non-indexed
LVEDD resulted in non-significant results between the
survivors and non-survivors, whereas indexed LVEDV led
to significant different results. Differences in using indexed
and non-indexed parameters are to be expected. While it
is natural for heart size to follow both body size, body
composition and physiological demands (for example,
exercise) to accommodate the greater metabolic needs, the
heart is also capable of adapting itself to acute conditions,
for example, dilating acutely with expanded intravascular
volume. According to our findings, the non-indexed
dimensions were more consistent across studies when
compared to indexed dimensions. Depending on which
parameter is used, this clearly has an impact on study
interpretations. More studies are needed in this area.
Excluded studies
Most studies were excluded due to a lack of sufficient
data. One relevant study was excluded because it
reported the results as median (25th/75th percentile),
and the author did not provide the data in mean (± SD)
when requested [38]. Nevertheless, the authors in that
study found no difference in LVEF between the survivor
and non-survivor groups. Unfortunately, we have to
exclude all studies published by Parker and colleagues
due to the inclusion of non-adults in their cohorts
[4,39,40]. It was also unclear if the patients were
recruited consecutively or if all the patients within the
study period were recruited. Another interesting point to
note about Parker’s 1984 studies is that the cohort con-
sisted of a large proportion (14 out of 20) of patients with
underlying malignancy, whether or not the cardiac func-
tion or dimensions of these patients were already affected
by the chemotherapy was unknown.
We also excluded studies that used other non-global
estimates for LV or RV function, such as tissue Doppler as
it only measures one segment of the myocardium [30].
Huang et al. Critical Care 2013, 17:R96
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Suggestions for future studies
Considering the challenges above, we suggest future
studies should be prospective in nature and use the
Consensus definition for recruitment. To improve gen-
eralizability, exclusion criteria should not be too restric-
tive and inclusion of patients with underlying cardiac
conditions should be considered. To handle possible
confounding effects of underlying cardiac conditions, a
priori plan of subgroups analyses can be made. The
sample size should be estimated beforehand based on
published data. To facilitate comparisons between stu-
dies, results should report the mean (SD), plus median
(95% CI) if necessary. Echocardiography remains as the
preferred methods for assessment at present. Although
echocardiography cannot assess RVEF, other estimates
of RV function (for example, tissue Doppler) can be
used instead. Treatments (vasopressors and inotropes)
given, and whether or not the patient received fluid, at
the time of assessment should be documented. Serial
measurements, at least for the first 2 to 3 days and after
fluid optimization and norepinephrine administration,
should be performed. While time-to-event survival ana-
lysis is the preferred method of analysis, ICU and in-
hospital mortality should be reported at the very least.
Limitations of the meta-analysis
The main purpose of meta-analysis is to summarize the
results from smaller studies in a systematic and unbiased
manner. Hence, the quality and conclusion of meta-
analysis depends on the quality of included studies. The
variability in study designs is one of the most concerned
factor in meta-analysis. In this study we addressed a
number of factors that could possibly explained results
heterogeneity and might also affect the quality of this
meta-analysis: sample size, definition of sepsis and septic
shock, study population, types of cardiac investigations,
and effects of therapy. To minimize results heterogeneity,
we used a list of objective and unbiased recruitment cri-
teria to identify appropriate studies. However, since
meta-analysis is retrospective in nature, statistical manip-
ulation could neither save the differences in study
designed nor improve the studies’ quality. As such,
we are unable to address several important issues due
to inconsistent study designs and lack of data: pre-
admission ventricular function, the precise effects of
early administration of vasopressors and inotropes, the
relationship between load-independent myocardial func-
tion index and mortality. A definitive answer to these
questions will require a large and well-designed prospec-
tive study.
Conclusions
By pooling 14 studies together, we managed to achieve a
reasonable sample size (>750) to examine the question
whether or not early ventricular dysfunction or dilata-
tion is associated with better mortality. We could not
find convincing evidence that initial low LVEF is asso-
ciated with better mortality in patients with severe sep-
sis or septic shock. Although survivors seemed to have
larger left ventricular size, the indexed LV dimensions
were similar in both groups. RVEF and RV dimension,
on the other hand, are not associated with mortality. In
view of these results, perhaps we should avoid using
ventricular dysfunction, especially LVEF, for prognosti-
cating patients with severe sepsis or septic shock. Since
many septic patients displayed reversible myocardial
depression, LVEF in these patients could be a mere
reflection of the balance between ventricular function
and loading conditions [41].
Key messages
• Most of the eligible primary studies were observa-
tional descriptive studies with limited sample size.
None of the studies were designed as prognosis stu-
dies using ejection fractions or ventricular dimen-
sions as prognosticator.
• Pooled results do not suggest survivors from severe
sepsis or septic shock had lower ejection fractions.
• Overall results seemed to suggest survivors exhib-
ited slightly larger LV dimensions but pooled
indexed LV dimensions were similar in survivors
and non-survivors.
• A more definitive larger trial is needed to confirm
these findings and to establish if indexed or non-
indexed dimensions should be used in clinical context.
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